Statins Evaluation in Coronary Procedures and Revascularization Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 4191 participants.
Also called NCT01448642
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 4,191 participants
- Registry
-
NCT01448642
-
- Main results
- Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial
- Other papers using this trial's data
- Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Brazil
- Registry status
- Completed
Technical summary
Registry record NCT01448642. Randomized; quadruple masking; primary purpose treatment. Start 2012-04 (actual); primary completion 2017-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Statins Evaluation in Coronary Procedures and Revascularization Trial
- Acronym
- SECURE-PCI
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Hospital do Coracao
- Collaborator
- Ministry of Health, Brazil
Record details
- Record id
cardio:ct-nct01448642- Content hash
5a6e614645243e4726b8f66c26d15b3ba898d7ba20c183ab9d6c4ace5e7470a9